Supriya Lifescience: Strong Operational Performance; FY25-26 Guidance Retained amid Expansion in CDMO
Moneylife Digital Team 13 June 2025
Supriya Lifescience Limited (Supriya) is into manufacturing of active pharmaceutical ingredients (APIs) in certain therapeutic segments, including anti-histamines, anti-allergic, vitamins,...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback